Floatz logo

(+)-VINCRISTINE

Adenocarcinoma of the Pancreas

Georgetown UniversitySmall moleculePhase 3Active
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
95/ 100

Competitive context

16 Active assets in the Adenocarcinoma of the Pancreas cohort.

Asset / SponsorPhaseRating
Docetaxel
Bristol-Myers Squibb
Phase 2BBB
Cediranib
University Health Network, Toronto
Phase 3BB
Veliparib
National Cancer Institute (NCI)
Phase 2BB
azd6244
AstraZeneca
Phase 2BB
Dasatinib
OHSU Knight Cancer Institute
Phase 2B

View all 47 →

Same molecule, other indications

(+)-VINCRISTINE is also rated in:

anaplastic large cell lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →